Reistone Biopharma Company Limited
Clinical trials sponsored by Reistone Biopharma Company Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Drug interaction study aims to unlock safer dosing for new lung therapy Results expected Sep 2026 (estimated)
- New ointment RSS0393 aims to clear psoriasis in major trial Results expected Jan 2027 (estimated)
-
New eczema ointment shows promise in early trial
Disease control CompletedThis study tested an ointment called RSS0393 in 168 adults with mild to moderate atopic dermatitis (eczema). Participants used different strengths of the ointment or a placebo for a set period. The goal was to see if the ointment could clear or nearly clear the skin rash. Results…
Phase 2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Healthy volunteers needed to test safety of new lung drug
Knowledge-focused CompletedThis early-stage study tests a new drug called RSS0343 in 48 healthy adults to see if it is safe and how the body handles it. Participants take the drug or a placebo by mouth for a short time. The goal is to check for side effects and measure drug levels in the blood. This study …
Phase 1 • Sponsor: Reistone Biopharma Company Limited • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC